NLRP3 and endometrial cancer: Estrogen-related receptor alpha (ERRα), a central regulator of cellular energy metabolism linked to poor cancer prognosis, enhances glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial cancer (152).